Bhaskar Chaudhuri's Net Worth
$11 Million
Who is Bhaskar Chaudhuri?
Bhaskar Chaudhuri has an estimated net worth of $11 Million. This is based on reported shares across multiple companies, which include IGI LABORATORIES, INC, Tarsus Pharmaceuticals, Inc., Arcutis Biotherapeutics, Inc., Corium International, Inc., and VALEANT PHARMACEUTICALS INTERNATIONAL.
SEC CIK
Bhaskar Chaudhuri's CIK is 0001458643
Past Insider Trading and Trends
2009 was Bhaskar Chaudhuri's most active year for acquiring shares with 14 total transactions. Bhaskar Chaudhuri's most active month to acquire stocks was the month of May. 2021 was Bhaskar Chaudhuri's most active year for disposing of shares, totalling 14 transactions. Bhaskar Chaudhuri's most active month to dispose stocks was the month of May. 2010 saw Bhaskar Chaudhuri paying a total of $2,870,900.69 for 101,358 shares, this is the most they've acquired in one year. In 2018 Bhaskar Chaudhuri cashed out on 96,123 shares for a total of $1,201,537.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IGI LABORATORIES, INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
∞
| 10K |
$0.70 | $7,005.00 | 10K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $30.59
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +167.50% | 3.35K |
—
|
—
| 5.35K |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $10.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.19% | 10.14K |
—
|
—
| 860.22K |
Jun 14
| |||
Form 4
| +0.52% | 4.38K |
—
|
—
| 850.08K |
May 31
| |||
Form 4
| +0.51% | 4.31K |
—
|
—
| 845.7K |
Jun 1
| |||
Form 4
| -0.88% | -7.48K |
$27.50 | -$205,810.00 | 841.39K |
Scheduled
|
Jun 24 - Jun 25
| ||
Form 4
| -0.30% | -2.52K |
$27.50 | -$69,190.00 | 848.88K |
Scheduled
|
Jun 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| -1.16% | -10.00K |
$27.50 | -$275,000.00 | 851.39K |
Scheduled
|
Jun 1
| ||
Form 4/A
| -1.15% | -10.00K |
$28.06 | -$280,568.20 | 861.39K |
Scheduled
|
Apr 20
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -1.15% | -10.00K |
$28.06 | -$280,568.20 | 861.39K |
Scheduled
|
Apr 20
| ||
Form 4
| -1.13% | -10.00K |
$31.10 | -$311,020.74 | 871.39K |
Scheduled
|
Mar 22
| ||
Form 4
| -1.12% | -10.00K |
$35.52 | -$355,190.93 | 881.39K |
Scheduled
|
Feb 22
| ||
Form 4
| -1.11% | -10.00K |
$33.22 | -$332,206.75 | 891.39K |
Scheduled
|
Jan 29 - Feb 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| +10.12% | 87.47K |
—
|
—
| 951.37K |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Corium International, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VALEANT PHARMACEUTICALS INTERNATIONAL No price found
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -333.44K |
—
|
—
|
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| +10.63% | 10.28K |
—
|
—
| 107.01K |
Sep 10 - Dec 10
| |||
Form 4
| +41.19% | 3K |
$33.31 | $99,928.20 | 10.28K |
Nov 20
| |||
Form 4
| +48.69% | 2.38K |
$33.58 | $80,097.12 | 7.28K |
Nov 18
| |||
Form 4
| +45.21% | 1.52K |
$32.81 | $50,039.22 | 4.9K |
Nov 10
| |||
Form 4
| +3.49% | 3.37K |
—
|
—
| 100.1K |
Sep 10
| |||
Form 4
|
∞
| 3.37K |
$26.69 | $90,026.38 | 3.37K |
Aug 14
| |||
Form 4
| +6.62% | 6.01K |
—
|
—
| 96.73K |
Jun 10
| |||
Form 4
| +1.51% | 1.35K |
$22.19 | $30,000.88 | 90.72K |
May 26
| |||
Form 4
| +1.55% | 1.36K |
$22.06 | $30,001.60 | 89.37K |
May 18
| |||
Form 4/A
| +4.06% | 3.44K |
—
|
—
| 88.01K |
May 11
| |||
Form 4
| +1.85% | 1.54K |
$19.50 | $29,991.00 | 84.57K |
May 11
| |||
Form 4
| +2.17% | 1.76K |
$17.05 | $30,008.00 | 83.03K |
May 4
| |||
Form 4
| +2.18% | 1.73K |
$17.32 | $29,998.24 | 81.27K |
Apr 27
| |||
Form 4
| +2.19% | 1.7K |
$17.62 | $30,006.86 | 79.54K |
Apr 20
| |||
Form 4
|
∞
| 77.84K |
—
|
—
| 77.84K |
Mar 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||